Fulcrum Therapeutics Inc (NASDAQ: FULC) kicked off on Tuesday, down -3.25% from the previous trading day, before settling in for the closing price of $12.92. Over the past 52 weeks, FULC has traded in a range of $2.32-$15.74.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 54.59%. While this was happening, its average annual earnings per share was recorded -633.13%.
Fulcrum Therapeutics Inc (FULC) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Fulcrum Therapeutics Inc is 11.30%, while institutional ownership is 82.21%. The most recent insider transaction that took place on Dec 15 ’25, was worth 44,876. Before that another transaction happened on Dec 08 ’25, when Company’s 10% Owner sold 4,175,139 for $13.98, making the entire transaction worth $58,377,021. This insider now owns 6,053,960 shares in total.
Fulcrum Therapeutics Inc (FULC) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.31 earnings per share (EPS), lower than consensus estimate (set at -0.29) by -0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.29 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -633.13% per share during the next fiscal year.
Fulcrum Therapeutics Inc (NASDAQ: FULC) Trading Performance Indicators
Take a look at Fulcrum Therapeutics Inc’s (FULC) current performance indicators. Last quarter, stock had a quick ratio of 17.70. For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.18, a number that is poised to hit -0.31 in the next quarter and is forecasted to reach -1.20 in one year’s time.
Technical Analysis of Fulcrum Therapeutics Inc (FULC)
The latest stats from [Fulcrum Therapeutics Inc, FULC] show that its last 5-days average volume of 2.4 million was superior to 0.75 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 58.74%.
During the past 100 days, Fulcrum Therapeutics Inc’s (FULC) raw stochastic average was set at 65.77%, which indicates a significant increase from 54.43% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.27 in the past 14 days, which was higher than the 0.67 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.89, while its 200-day Moving Average is $6.94. Now, the first resistance to watch is $12.85. This is followed by the second major resistance level at $13.20. The third major resistance level sits at $13.40. If the price goes on to break the first support level at $12.30, it is likely to go to the next support level at $12.10. Assuming the price breaks the second support level, the third support level stands at $11.75.
Fulcrum Therapeutics Inc (NASDAQ: FULC) Key Stats
The company with the Market Capitalisation of 824.63 million has total of 54,118K Shares Outstanding. Its annual sales at the moment are 80,000 K in contrast with the sum of -9,730 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -19,600 K.
